• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18氟脱氧葡萄糖正电子发射断层扫描与67镓闪烁扫描在非霍奇金淋巴瘤化疗期间作为预后检测方法的比较

18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma.

作者信息

Zijlstra Josée M, Hoekstra Otto S, Raijmakers Pieter G H M, Comans Emile F I, van der Hoeven Jacobus J M, Teule Gerrit J J, Jonkhoff A Roelof, v Tinteren Harm, Lammertsma Adriaan A, Huijgens Peter C

机构信息

Department of Hematology Clinical PET Center, VU University Medical Center, Hospital Amstelveen, Amsterdam, The Netherlands.

出版信息

Br J Haematol. 2003 Nov;123(3):454-62. doi: 10.1046/j.1365-2141.2003.04617.x.

DOI:10.1046/j.1365-2141.2003.04617.x
PMID:14617005
Abstract

A prospective study was performed, comparing gallium scintigraphy (67Ga) and positron emission tomography (PET) using fluorine-18 fluorodeoxyglucose (18FDG), to monitor the response of aggressive non-Hodgkin's lymphoma during treatment. 67Ga and 18FDG scans were performed in 26 patients after two cycles of CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) therapy. The scans were reviewed independently by four experienced nuclear physicians, who were blinded for the alternative scan technique and follow-up. Eleven out of 26 patients remained free from progression with a mean follow up of 25 +/- 5 months, whereas 14 patients relapsed, and one died of lung cancer. Interobserver variation was significantly greater for 67Ga than for 18FDG PET. Some 64% of patients who had a negative early restaging 18FDG PET remained free from progression versus 50% of patients with negative 67Ga scans. Only 25% of patients with a positive PET remained disease free versus 42% of 67Ga-positive patients. Time to progression was associated with 18FDG PET results, but not with those by 67Ga. 18FDG PET had better test characteristics than 67Ga for the evaluation of early response in aggressive non-Hodgkin's lymphoma patients.

摘要

进行了一项前瞻性研究,比较了镓闪烁扫描(67Ga)和使用氟-18氟脱氧葡萄糖(18FDG)的正电子发射断层扫描(PET),以监测侵袭性非霍奇金淋巴瘤在治疗期间的反应。在26例患者接受两个周期的CHOP(环磷酰胺、阿霉素、长春新碱、泼尼松)治疗后,进行了67Ga和18FDG扫描。由四位经验丰富的核医学医师独立审查扫描结果,他们对替代扫描技术和随访情况不知情。26例患者中有11例病情无进展,平均随访25±5个月,而14例患者复发,1例死于肺癌。67Ga的观察者间差异显著大于18FDG PET。早期重新分期18FDG PET结果为阴性的患者中约64%病情无进展,而67Ga扫描结果为阴性的患者中这一比例为50%。PET结果为阳性的患者中只有25%无病生存,而67Ga结果为阳性的患者中这一比例为42%。疾病进展时间与18FDG PET结果相关,但与67Ga结果无关。在评估侵袭性非霍奇金淋巴瘤患者的早期反应方面,18FDG PET比67Ga具有更好的检测特征。

相似文献

1
18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma.18氟脱氧葡萄糖正电子发射断层扫描与67镓闪烁扫描在非霍奇金淋巴瘤化疗期间作为预后检测方法的比较
Br J Haematol. 2003 Nov;123(3):454-62. doi: 10.1046/j.1365-2141.2003.04617.x.
2
Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.早期再分期的镓扫描可预测接受大剂量CHOP化疗的侵袭性非霍奇金淋巴瘤预后不良患者的治疗结果。
J Clin Oncol. 1997 Apr;15(4):1631-7. doi: 10.1200/JCO.1997.15.4.1631.
3
18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients.18氟脱氧葡萄糖正电子发射断层显像(18FDG PET)与高剂量67镓闪烁显像用于淋巴瘤患者的再分期及治疗随访
Nucl Med Commun. 2002 Nov;23(11):1079-83. doi: 10.1097/00006231-200211000-00007.
4
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.采用(18)F - 氟脱氧葡萄糖进行早期再分期的正电子发射断层扫描可预测侵袭性非霍奇金淋巴瘤患者的预后。
Ann Oncol. 2002 Sep;13(9):1356-63. doi: 10.1093/annonc/mdf256.
5
Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.正电子发射断层扫描(PET)阳性非霍奇金淋巴瘤的联合治疗模式:伴有非霍奇金淋巴瘤且化疗后正电子发射断层扫描(PET)氟脱氧葡萄糖(FDG-PET)阳性的患者,采用联合治疗模式可获得良好的转归。
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e647-54. doi: 10.1016/j.ijrobp.2012.01.060. Epub 2012 May 18.
6
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.用镓-67、CT扫描和磁共振成像监测霍奇金病和高级别非霍奇金淋巴瘤的纵隔大肿块病变。
Leuk Lymphoma. 1996 Jun;22(1-2):131-5. doi: 10.3109/10428199609051740.
7
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).弥漫性大 B 细胞淋巴瘤患者采用 R-CHOP-14(SAKK 38/07)治疗中中期正电子发射断层扫描预测价值的前瞻性评估的最终结果。
J Clin Oncol. 2015 Aug 10;33(23):2523-9. doi: 10.1200/JCO.2014.58.9846. Epub 2015 Jul 6.
8
Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.(18)F-FDG 杂交正电子发射断层显像/计算机断层扫描对非霍奇金淋巴瘤患者自体干细胞移植前后临床结局的预测价值
Hematology. 2010 Feb;15(1):21-7. doi: 10.1179/102453310X12583347009739.
9
Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.评估肿瘤大小缩小可改善晚期霍奇金淋巴瘤化疗后正电子发射断层扫描/计算机断层扫描的预后预测。
J Clin Oncol. 2014 Jun 10;32(17):1776-81. doi: 10.1200/JCO.2013.53.2507. Epub 2014 May 5.
10
Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma.非霍奇金淋巴瘤的计算机断层扫描、磁共振成像和正电子发射断层扫描
Acta Radiol Suppl. 1998;417:1-36.

引用本文的文献

1
Toxic encephalopathy.中毒性脑病。
Saf Health Work. 2012 Dec;3(4):243-56. doi: 10.5491/SHAW.2012.3.4.243. Epub 2012 Nov 30.
2
Overview of early response assessment in lymphoma with FDG-PET.利用氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)对淋巴瘤早期反应进行评估的概述。
Cancer Imaging. 2007;7(1):10-8. doi: 10.1102/1470-7330.2007.0004.
3
Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography.用于正电子发射断层扫描监测钇-泽瓦林生物分布的锆-泽瓦林的制备与评估
Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1337-45. doi: 10.1007/s00259-006-0160-0. Epub 2006 Jul 11.
4
Use of FDG-PET to monitor response to chemotherapy and radiotherapy in patients with lymphomas.使用氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)监测淋巴瘤患者对化疗和放疗的反应。
Eur J Nucl Med Mol Imaging. 2006 Jul;33 Suppl 1:22-6. doi: 10.1007/s00259-006-0132-4.